EUVIMEDEUVIMED entdecken
Open Access

Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin

Kandiah Chandrakumaran, Norman John Carr, Faheez Mohamed, Thomas Desmond Cecil, Brendan John Moran

JAMA Surgery · 2023

DOI: 10.1001/jamasurg.2023.0112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Surgery, 2023. Verfasst von Kandiah Chandrakumaran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom. Hauptthemen laut MEDLINE: Pseudomyxoma Peritonei, Peritoneal Neoplasms, Hyperthermia, Induced, Appendiceal Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Pseudomyxoma peritoni, a rare condition characterized by mucinous ascites and peritoneal deposits, mainly originates from a ruptured mucinous appendix tumor and is considered an indolent disease but can progress and become fatal. Optimal treatment to improve cure and survival rates involves complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Accurate predictive models are useful in supporting and informing treatment strategies and stratifying patient follow-up.

Objective

To evaluate the prognostic significance of clinically important variables and generate validated nomograms to predict overall (OS) and disease-free survival (DFS) following CCRS and hyperthermic intraperitoneal HIPEC for pseudomyxoma peritonei (PMP) of appendiceal origin. Design, Setting, and Participants This retrospective study used prospectively collected data on patients who had cytoreductive surgery (CRS) and HIPEC in a single institution between 1994 and 2018. The cohort was randomly allocated into development (70%) and validation (30%) sets. Univariate and multivariate analyses were performed with Cox proportional hazards regression. Main Outcomes and Measures A prediction model was developed with significant prognostic factors identified by multivariate analysis. The model’s prognostic performance was evaluated with the concordance index (C index). The nomogram was calibrated by comparing the predicted and observed probabilities.

Results

Of 2637 CRS and HIPEC operations, 1102 patients (female, 64.4%; median age [IQR], 57.0 [48.0-66.0] years) (41.8%) had CCRS for PMP of appendiceal origin. Elevated tumor markers, peritoneal carcinomatosis index, gastrectomy, and tumor grade were independent predictive factors for DFS. Gender, age, elevated tumor makers, peritoneal carcinomatosis index, and tumor grade influenced OS. The nomograms were generated with respective prognostic factors. The nomograms showed good performance in predicting survival. Median OS of the cohort was 16.5 years (95% CI, 13.7-19.2) with a 5-year probability of survival of 80.2%. The median DFS was 10.3 years (95% CI, 7.2- 13.3) and the 5-year probability of recurrence-free survival was 60.5%. Conclusions and Relevance Clinically important independent predictors for survival and recurrence were selected to develop the nomograms for OS and DFS. These 2 nomograms are user friendly and useful tools for patient management with clinical trial design applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomyxoma PeritoneiPeritoneal NeoplasmsHyperthermia, InducedAppendiceal NeoplasmsHumansFemaleMiddle AgedPrognosisHyperthermic Intraperitoneal ChemotherapyNomogramsCytoreduction Surgical ProceduresRetrospective StudiesTreatment OutcomeCombined Modality Therapy

Autor:innen und Institutionen

  • Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom.

Zitieren

APA

Chandrakumaran, K., Carr, N. J., Mohamed, F., Cecil, T. D., & Moran, B. J. (2023). Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin. JAMA Surgery. https://doi.org/10.1001/jamasurg.2023.0112

Vancouver

Chandrakumaran K, Carr NJ, Mohamed F, Cecil TD, Moran BJ. Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin. JAMA Surgery. 2023. doi:10.1001/jamasurg.2023.0112

BibTeX
@article{Chandrakumaran2023,
  author = {Chandrakumaran, Kandiah and Carr, Norman John and Mohamed, Faheez and Cecil, Thomas Desmond and Moran, Brendan John},
  title = {Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin},
  journal = {JAMA Surgery},
  year = {2023},
  doi = {10.1001/jamasurg.2023.0112}
}
Kostenlos starten →